US Broker Ratings

Novo Nordisk A/S (NVO) Stock Analysis: Navigating Growth and Valuation Challenges

Novo Nordisk A/S (NYSE: NVO), a leading player in the global healthcare sector, is known for its stronghold in the pharmaceutical industry, particularly in the areas of diabetes and obesity..

Novartis AG (NVS) Investor Outlook: Navigating a Balanced Path Amidst Market Volatility

Novartis AG (NYSE: NVS), a heavyweight in the global pharmaceutical industry, remains a focal point for investors seeking both stability and growth potential in the healthcare sector. With a substantial..

Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating Growth Potential and Analyst Ratings

Becton, Dickinson and Company (NYSE: BDX), a prominent player in the healthcare sector, stands out as a key manufacturer and supplier of medical supplies and diagnostic equipment. With a market..

Sanofi (SNY) Stock Analysis: Exploring a 29% Potential Upside with Strong Dividend Yield

Sanofi (SNY), a global leader in the healthcare sector, presents an intriguing investment opportunity for those seeking exposure to the pharmaceutical industry. With a market capitalization of $103.32 billion, the..

Haleon plc (HLN) Stock Analysis: Unlocking an 18.64% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, continues to capture the attention of investors with its robust product portfolio and significant potential upside. Headquartered in Weybridge, United..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the 101% Return on Equity Amid a Diverse Portfolio

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of therapeutics and impressive financial metrics. As a leading player in..

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with a 22.35% Upside Potential

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to attract investor attention with its robust portfolio of medical devices and healthcare products. With a market capitalization of..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with a 3.91% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, renowned for its pioneering work in developing treatments for serious diseases such as cystic fibrosis and..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a 26.42% ROE and Steady Dividend Yield

Johnson & Johnson (NYSE: JNJ) remains a stalwart in the healthcare sector, commanding a market capitalization of $633.19 billion. Known for its diverse portfolio in the fields of Innovative Medicine..

Option Care Health, Inc. (OPCH) Stock Analysis: A 31% Upside Potential Amid Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector may want to closely examine Option Care Health, Inc. (NASDAQ: OPCH), a key player in the medical care facilities industry. With..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 92.85% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) has recently captured investor attention with its promising position in the biotech sector, driven by innovative vaccine development and significant upside potential. With a current market..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands out as a key player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $8.05 billion, this..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unveiling a 35% Upside Potential with Robust Analyst Ratings

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, is making waves with its diverse portfolio of over-the-counter (OTC) health and personal care products. With a market..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a Potential 69% Upside in the Healthcare Tech Space

For investors looking at the intersection of healthcare and technology, Waystar Holding Corp. (NASDAQ: WAY) presents an intriguing opportunity. Specializing in cloud-based software solutions for healthcare payments, Waystar has carved..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 100% Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector, particularly with its promising pipeline of novel cell therapies. Despite the challenges inherent in the biotech industry, Legend..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Biotech Company Poised for Nearly 90% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) stands as a compelling opportunity within the biotechnology sector, particularly for investors with an appetite for high-growth potential. With a market capitalization of $225.62 million,..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Collaborations

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, has carved a niche for itself in the healthcare industry through its innovative approach to drug development and strategic..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Stable Horizon with Strong Cash Reserves

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a prominent player in the biotechnology sector, commands a market capitalization of $2.76 billion. Headquartered in Redwood City, California, Soleno Therapeutics specializes in developing and..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring the 52.60% Revenue Growth in the Expanding Healthcare Sector

Oscar Health, Inc. (OSCR) is making waves in the healthcare sector, capturing investor attention with an impressive 52.60% revenue growth. Headquartered in New York, Oscar Health operates as a healthcare..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Marvel with 31.9% Revenue Growth and Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a formidable player in the biotechnology sector, with a market capitalization of $10.97 billion. Specializing in genetic medicines targeting diseases with significant..

Search

Funds

April 14, 2026

Search

Funds

US Broker Ratings

FTSE 100

Funds